Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | MEDI9197 |
| Trade Name | |
| Synonyms | MEDI-9197|MEDI 9197|Telratolimod|3M-052|3M 052 |
| Drug Descriptions |
MEDI9197 (telratolimod) acts an an agonist for the TLR7 and TLR8, potentially resulting in increased anti-tumor immune response (J Clin Oncol 34, 2016 (suppl; abstr TPS3095), PMID: 31511088). |
| DrugClasses | TLR7 Agonist 13 TLR8 Agonist 10 |
| CAS Registry Number | 1359993-59-1 |
| NCIT ID | C124653 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Durvalumab + MEDI9197 | Durvalumab MEDI9197 | 0 | 1 |
| MEDI9197 | MEDI9197 | 0 | 1 |